Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 5, 2008, Pages 1099-1102

  Rose, Warren E ^a,b,c   Kaatz, Glenn W ^a,d,e   Sakoulas, George ^f   Rybak, Michael J ^a,b,d  

^a WAYNE STATE UNIVERSITY   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e John D Dingell Department of Veteran's Affairs Medical Center   (United States)

^f NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Glycopeptides; Quorum sensing; Resistance

Indexed keywords

ACCESSORY GENE REGULATOR; GLYCOPEPTIDE; REGULATOR PROTEIN; TEICOPLANIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE ESCALATION; GENE FUNCTION; GENE MUTATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; OPERON; PHARMACODYNAMICS; QUORUM SENSING; REGULATOR GENE; SIMULATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; TIME FACTORS; TRANS-ACTIVATORS;

EID: 42149121369     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn037     Document Type: Article

References (10)

1. Mwangi MM, Wu SW, Zhou Y et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104: 9451-6.
2. Sakoulas G, Eliopoulos GM, Moellering RC, Jr et al. Aocessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002; 46: 1492-502.
3. Rose WE, Rybak MJ, Tsuji BT et al. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function. J Antimicrob Chemother 2007; 59: 1190-3.
4. Shlaes DM, Shlaes JH. Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin. Clin Infect Dis 1995; 20 1071-3.
5. Shlaes DM, Shlaes JH, Vincent S et al. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob Agents Chemother 1993; 37: 2432-7.
6. Kaatz GW, Seo SM, Dorman NJ et al. Emergence of teicoplanin resistance during therapy of Staphtlococcus aureus endocarditis. J Infect Dis 1990; 162: 103-8.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing - Sixteenth Edition: Approved Standard M100-S16. CLSI, Wayne, PA, USA, 2006.
8. Erickson RC, Hildebrand AR, Hoffman PF et al. A sensitive bioassay for teicoplanin in serum in the presence or absence of other antibiotics. Diagn Microbiol Infect Dis 1989; 12: 235-41.
9. Moise-Broder PA, Sakoulas G, Eliopoulos GM et al. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis 2004; 38: 1700-5.
10. Renzoni A, Francois P, Li D et al. Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48: 2958-65.